Polaryx Therapeutics, Inc. PLYX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Polaryx Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Polaryx Therapeutics, Inc. 's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Polaryx Therapeutics, Inc. 's financing cash flow?
- Polaryx Therapeutics, Inc. (PLYX) reported financing cash flow of $250K in Q1 2025.
- How has Polaryx Therapeutics, Inc. 's financing cash flow changed year-over-year?
- Polaryx Therapeutics, Inc. 's financing cash flow decreased by 86.1% year-over-year, from $1.8M to $250K.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.